OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
Medicare Prescription Drug Improvement Act required a study to make information about prescription drugs available to the visually impaired
On May 20, 2004, the Medicare Prescription Drug Improvement and Modernization Act, signed in 2003, required among other…
UN Food and Agriculture Organization endorsed biotech crops
On May 17, 2004, the United Nations Food and Agriculture Organization endorsed biotech crops, stating biotechnology is a…
University of Alabama Mecial Center’s new multi-specialty clinic and College of Community Health Sciences opened
On May 11, 2004, the University of Alabama Medical Center’s opened a new $13.5 million 77,000 square foot…
An international call-to-action issued to conduct the annual observance of World Lupus Day
On May 10, 2004, an international call-to-action has been issued by more than one hundred lupus organizations based…
The Health Sciences Learning Center opened near the University of Wisconsin Hospital
On May 7, 2004, the Health Sciences Learning Center opened near the University of Wisconsin Hospital and Clinics….
NIAID awarded a new license agreement for RotaShield, an oral rotavirus vaccine
On May 4, 2004, the National Institute of Allergy and Infectious Diseases (NIAID), awarded a new license agreement…
DNA Day commemorates the successful completion of the Human Genome Project and discovery of DNA’s double helix
On April 25 known as DNA Day, is a day that commemorates the successful completion of the Human…
The Virginia Bioinformatics Institute opened Bioinformatics Facility I
On Apr. 24, 2004, the Virginia Bioinformatics Institute, opened its new 59,000-square-foot Bioinformatics Facility I The mission of…
Eli Lilly and Company launched Symbyax in the U.S.
On Apr. 19, 2004, Eli Lilly and Company launched Symbyax in the U.S., the first and only Food…
Biotechnology | Diagnostics | Disease | Environmental | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
The National Center for Vermiculite and Asbestos-Related Cancers was established
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
The Priestley Medal was awarded to Elias J. Corey
Mar. 30, 2004, the American Chemical Society awarded the Priestley Medal to Elias J. Corey “to recognize distinguished…
Tetanus and diphtheria toxoids adsorbed for adult use, preservative-free, was licensed
On Mar. 24, 2004, the U.S. Food and Drug Administration (FDA) licensed tetanus and diphtheria toxoids adsorbed for…
Biotechnology | Diagnostics | FDA | Life Science News | NIH | Oncology
The FDA and NCI announced they will share knowledge and resources to facilitate development of new cancer drugs
On Mar. 16, 2004, the Food and Drug Administration (FDA) released a report addressing the recent slowdown in…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute of Neuroscience at Yale University
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
The Kavli Foundation established the Kavli Institute for Brain and Mind at the University of California, San Diego
On Mar. 19, 2004, University of California, San Diego (UCSD) was awarded $7.5 million to establish The Kavli…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute for Brain Science at Columbia University Medical Center
On Mar. 10, 2004, The Kavli Foundation announced a $7.5 million award to establish a Kavli Institute for…
The National incident Management System was established to coordinate response for public health incidents
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
FDA approved the first antiangiogenic drug for cancer, Avastin
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
FDA banned dietary supplements containing ephedrine alkaloids
On Feb. 9, 2004, deeming such products to present an unreasonable risk of harm, the FDA banned dietary…
The monoclonal antibody cetuximab (Erbitux) was approved by the FDA for the treatment of metastatic colorectal cancer
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Ophthalmogy | Therapeutics
OHSU School of Medicine’s Casey Eye Institute received $2.6 million to study glaucoma
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
The International Tomato Genome Sequencing Project was launched
On Jan. 28, 2004, the International Tomato Genome Sequencing Project was begun by an international consortium including participants…
The U.S. Congress enacted the Sun Grant Research Initiative Act
On Jan. 23, 2004, the U.S. Congress enacted the Sun Grant Research Initiative Act. The Sun Grant Research…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
The FDA approved oxaliplatin (Eloxatin) for use in the treatment of advanced colorectal cancer
On Jan. 9, 2004, the Food and Drug Administration (FDA) announced the approval of Sanofi’s Eloxatin (oxaliplatin) injection…
Siemens introduced Acuris, the first hearing instrument featuring a wireless system, e2e wireless, small enough to fit in CICs
In 2004, Siemens, now Sivantos, introduced Acuris, the first hearing instrument featuring a wireless system, e2e wireless, small…
FDA issued public health advisory urging health professionals to limit the use of Cox-2 selective agents
In 2004, Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib) because of an increased risk of heart…
The Division of Global Migration and Quarantine controlled quarantine issues in the U.S.
In 2004, The Division of Global Migration and Quarantine, part of the CDC’s National Center for Infectious Diseases,…
Anabolic Steroid Control Act banned OTC steroid precursors and increased penalties for illegal steroids
In 2004, the U.S. Congress passed the Anabolic Steroid Control Act which enacted a ban on over-the-counter steroid…
FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New Medical Products”
In 2004, the FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New…